Mary Joyner

HIV-infected women and infants: Social and health factors impeding utilization of health care☆

The utilization of health care by HIV-seropositive pregnant women and their infants was studied in an indigent urban population. Ninety HIV-seropositive women delivered 99 HIV-exposed infants at the Johns Hopkins Hospital from August 1, 1988, to April 1, 1991. Repeat pregnancies occurred in 17 (18.9%) women during the study period. Completion of the primary immunization series by age nine months was the criteria for infant adherence to medical care. Of all infants, 72.9% achieved adequate immunization status by nine months. However, only 41 (45.6%) women reported ever seeking HIV-related health care. Factors associated with maternal adherence with HIV-related health care included HIV status of her infant, maternal drug use, and incarceration. Number of living children, maternal age, educational level, marital status, and repeat pregnancy were not associated with mothers seeking HIV-related health care. Despite low adherence to HIV-related health care in this sample of HIV-seropositive women, the majority of their infants did receive adequate immunizations, one proxy measure of adequate infant health care.

Antibody Response To Hepatitis A Immunization Among Human Immunodeficiency Virus-infected Children And Adolescents

Seventy-one of 84 human immunodeficiency virus (HIV)-infected children [84.5% (95% confidence interval: 75–91.5%)] were hepatitis A virus (HAV) seropositive after 2 doses of HAV vaccine. Higher CD4% and HIV suppression were significantly associated with increased HAV seropositivity rate. In multivariate analysis, CD4 ≥25% and young age were independent predictors of HAV seropositivity. Of 7 children given a third HAV vaccine dose because of negative HAV antibody after 2 doses, 2 (29%) became seropositive.

Primary care for children with human immunodeficiency virus infection

Pediatric human immunodeficiency virus (HIV) infection is now the seventh leading cause of death in U.S. children 1 to 14 years of age and the leading cause of death in children 2 to 5 years of age in many U.S. cities. The key to enhancing the quality and duration of life in HIV-infected children is to recognize and diagnose HIV infection as early as possible and to initiate prophylactic and antiretroviral therapies. Most of the medical treatment of these children can be conducted in a primary care setting if (a) primary care practitioners are informed of current treatment regimens and (b) adequate pediatric HIV consultation service is available. This article reviews the primary care of HIV-infected children including early diagnosis, current treatment options, and the complex psychosocial issues associated with caring for these children.

Care of HIV-risk infants: Nursing outreach by PNPs

In this prospective study, HIV-risk infants (infants born to women with a history of intravenous drug use, prostitution, or who is a sexual partner of an intravenous drug user) were followed during home visits by a pediatric nurse practitioner. Analysis of home visit records indicated that significant medical problems were detected in one out of every 12 visits, requiring referral of the infant for immediate medical attention. The most frequent problems/maternal concerns encountered during the home visits were infectious disease symptoms and skin conditions. The type of problems/maternal concerns did not differ by infant HIV status. With an increase in incidence of HIV infection in children, outreach by specialized nurses including PNPs is necessary to provide the intensive medical services required by these children.

Epstein-Barr Virus—Associated Central Nervous System Lymphoproliferative Disease in a Patient with Acquired Immunodeficiency Syndrome Responsive to Highly Active Antiretroviral Therapy

A 20-year-old man with acquired immunodeficiency syndrome (AIDS) and central nervous system (CNS) lymphoproliferative disease experienced improvement with highly active antiretroviral therapy (HAART) without radiation therapy. Our experience highlights the importance of biopsy in evaluating multifocal radiographic CNS lesions and the central role of HAART in treating AIDS-related CNS disease.